Speakers

Pr Maria Federova; Center for Biotechnology and Biomedicine, Universität Leipzig, Germany

Abstract: Targeted LC-MS quantification of non-enzymatically generated isoprostanes and neuroprostanes

Pr Joan Claria; Biochemistry and Molecular Genetics Service-Hospital Clínic and Department of Biomedicine-School of Medicine-University of Barcelona, Barcelona, Spain

Abstract: Role of omega-3-derived lipid mediators in the resolution of inflammation in insulin-sensitive tissues

Pr Feliciano Priego-Capote:  Department of Analytical Chemistry, University of Cordoba, Spain

Abstract: Confirmatory and quantitative analysis of fatty acid esters of hydroxy fatty acids in serum by solid phase extraction coupled to liquid chromatography tandem mass spectrometry

Dr Claire Vigor; Institut des Biomolécules Max Mousseron, CNRS UMR 5247, Université de Montpellier, ENSCM, France

Abstract:  Isoprostanes, neuroprostanes, phytoprostanes: what we could do with those non enzymatic oxidized lipids?

Dr Manuel Pazos; Consejo Superior de Investigaciones Científicas  Instituto de Investigaciones Marinas de Vigo, (IIM-CSIC), Eduardo Cabello 6, 36298 Spain

Abstract: Oxidative stress in diet-induced metabolic disorders and its modulation by omega-3 PUFA from marine origin

Dr Julia Kuligowski; Neonatal Research Group, Health Research Institute Hospital La Fe, Bulevar Sur s/n, 46026 Valencia, Spain

Abstract: Oxidative Stress Biomarkers in the Preterm Infant

Pr Claudio De Felice;  Neonatal Intensive Care Unit, Azienda Ospedaliera Universitaria Senese, Siena, Italy

Abstract: Biological effects of isoprostanes and neuroprostanes: from Rett Syndrome to brain disease

Pr Lourdes Ruiz Desviat; Departamento de Biologia Molecular, Facultad de Ciencias,Universidad Autonoma de Madrid, Madrid, Spain

 Abstract: Mitochondrial dysfunction and oxidative damage contribute to the pathophysiology of the neurometabolic disease propionic acidemia